Exponent (NASDAQ:EXPO) had its price objective boosted by SunTrust Banks from $70.00 to $81.00 in a research note issued to investors on Friday morning, The Fly reports. SunTrust Banks currently has a buy rating on the business services provider’s stock. SunTrust Banks also issued estimates for Exponent’s Q2 2020 earnings at $0.40 EPS, Q3 2020 earnings at $0.39 EPS, Q4 2020 earnings at $0.37 EPS, FY2020 earnings at $1.57 EPS and FY2021 earnings at $1.71 EPS.
EXPO has been the topic of a number of other research reports. DA Davidson started coverage on Exponent in a research report on Wednesday, August 28th. They set a neutral rating on the stock. BidaskClub upgraded Exponent from a hold rating to a buy rating in a research report on Friday. Cantor Fitzgerald lifted their price objective on Exponent from $64.00 to $73.00 and gave the stock an overweight rating in a research report on Friday, July 19th. Zacks Investment Research downgraded Exponent from a buy rating to a hold rating in a research report on Wednesday, September 18th. Finally, ValuEngine upgraded Exponent from a sell rating to a hold rating in a research report on Wednesday, September 4th. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The company presently has a consensus rating of Hold and a consensus price target of $76.67.
NASDAQ EXPO opened at $70.73 on Friday. The company has a market cap of $3.72 billion, a PE ratio of 50.05 and a beta of 0.43. The stock’s 50 day simple moving average is $69.92 and its 200-day simple moving average is $61.10. Exponent has a 1-year low of $44.44 and a 1-year high of $72.70. The company has a debt-to-equity ratio of 0.05, a current ratio of 3.60 and a quick ratio of 3.60.
The business also recently disclosed a quarterly dividend, which was paid on Friday, September 20th. Investors of record on Friday, September 6th were given a dividend of $0.16 per share. The ex-dividend date was Thursday, September 5th. This represents a $0.64 dividend on an annualized basis and a yield of 0.90%. Exponent’s payout ratio is 51.20%.
In other Exponent news, CFO Richard L. Schlenker, Jr. sold 22,243 shares of Exponent stock in a transaction on Tuesday, August 20th. The stock was sold at an average price of $70.57, for a total value of $1,569,688.51. Following the sale, the chief financial officer now owns 247,118 shares in the company, valued at $17,439,117.26. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider John Pye sold 3,000 shares of Exponent stock in a transaction on Friday, August 9th. The shares were sold at an average price of $70.31, for a total value of $210,930.00. Following the completion of the sale, the insider now owns 25,747 shares in the company, valued at approximately $1,810,271.57. The disclosure for this sale can be found here. In the last quarter, insiders have sold 102,773 shares of company stock worth $7,227,536. 2.30% of the stock is currently owned by company insiders.
A number of large investors have recently bought and sold shares of EXPO. Nuveen Asset Management LLC purchased a new stake in Exponent in the second quarter valued at $34,946,000. FMR LLC grew its stake in shares of Exponent by 39.8% in the first quarter. FMR LLC now owns 993,288 shares of the business services provider’s stock valued at $57,333,000 after buying an additional 282,530 shares in the last quarter. Morgan Stanley grew its stake in shares of Exponent by 82.4% in the second quarter. Morgan Stanley now owns 359,112 shares of the business services provider’s stock valued at $21,023,000 after buying an additional 162,208 shares in the last quarter. Conestoga Capital Advisors LLC grew its stake in shares of Exponent by 4.4% in the second quarter. Conestoga Capital Advisors LLC now owns 2,422,012 shares of the business services provider’s stock valued at $141,785,000 after buying an additional 102,845 shares in the last quarter. Finally, Nicholas Company Inc. acquired a new stake in shares of Exponent in the second quarter valued at $5,204,000. Institutional investors own 88.08% of the company’s stock.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.
Featured Story: Diversification
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.